A daylong session moderated by AACC Annual Meeting Chair Paolo Fortina MD, PhD, Thomas Jefferson University (Philadelphia, PA), will be devoted to an overview of the present and future of diagnostics technology. The session will require a significant investment of your time—it runs from 10:30 AM to 5 PM today (July 18)—but all indications are that the ROI will be substantial.
The session will present an overview of novel clinical testing technologies starting with new methods for blood collection, nucleic acid extraction, microchip devices, and gene signature and digital RNA analysis in clinical settings using innovative platforms and protocols, according to event organizers.
Targeting medical technologists, IVD industry scientists, geneticists, clinical and molecular pathologists, among others, the session promises to provide insights on:
- newly developed approaches for blood sampling
- microfabricated devices that integrate sequential assay steps on small, disposable products
- currently available technologies for multiplex digital measurements of mRNA abundance
- the merits of novel targeted arrays as cost-effective tools for diagnosis and monitoring of drug treatment
- new developments in single molecule immunoassay.
The topics and speakers are as follows:
Blood Collection: New Methods with Far Reaching Consequences
Stefan Roever, Mountain View
Clinical Applications of Microchip Devices
Jing Cheng, PhD, CapitalBio Corp., Beijing, China
Diagnostic Microarrays in Hematological Malignancies: Improved Molecular Sub-typing of AML Patients
Thomas Dijkmans, PhD, Skyline Diagnostics, Rotterdam, Netherlands
Counting on Precise, Digital Measurements for Translational Research
Gary Geiss, PhD, Nanostring Technologies, Seattle, WA
Single-Molecule Detection Technology in Clinical Analysis
David Walt, PhD, Tufts University, Medford, MA